The expression of secretory component (SC) by human glandular endometrial cells cultured in vitro was significantly increased by estradiol in the medium. Interferongamma and interleukin-4 stimulated the expression of SC only in the presence of estrogen. Tumor necrosis factoralpha plus estrogen also caused a significant increase in the number of cells expressing SC. HLA class II antigen DR was detected on few glandular epithelial cells of human endometrium cultured in control medium, whereas interferon-gamma and interleukin-4, but not tumor necrosis factor-alpha, caused significant increases in the expression of DR. Estrogen in the culture medium did not significantly affect DR expression. The human endometrial adenocarcinoma cell lines, HEC and RL-95, expressed SC in approximately 50 and 20% of the cells. Also, approximately 20% of the RL-95 cells stained for DR antigen. Interferon-gamma did not influence the degree of expression of either surface marker of the two cell lines. Cells of both lines bound polymeric IgA and IgM but showed little to no binding of monomeric IgA, IgG, or an IgM previously shown not to bind SC.
INTRODUCTION
The female genital tract is one of the organs and tissues that compose the common mucosal immune 
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system also known as the secretory immune system (1, 2) . The mucosal immune system secretes more immunoglobulin (Ig), primarily of the IgA isotype, than the total Ig of all classes originating from bone marrow, spleen, and lymph nodes combined (3) . Secreted IgA functions as the first line of defense for the mucosal surfaces. Both serum-derived and locally produced antibodies are found in the cervicovaginal secretions of women (4) (5) (6) (7) (8) (9) .
An integral part of the secretory immune system is the secretory component (SC), the receptor for polymeric Ig (pig) (10) . The transport of plgA or pentameric IgM, produced by the plasma cells located in the subepithetial tissues, to the lumen of mucosal organs is dependent on the expression of SC on epithelial cells that binds the pig on the basolateral surface. The SC-plg complex is internalized, transported to the apical surface, and secreted into the lumen as S-IgA or S-IgM. Glandular epithelial cells from the human fallopian tubes, uterine endometrium, and cervix have been shown to produce and express surface SC (11) (12) (13) (14) . The secretion and expression of SC by the endometrium appears to be influenced by the stage of the menstrual cycle (11, 14) . In addition, adenocarcinomas of the human endometrium also express SC on the epithelial surface (11, 15) .
The HLA class II antigen, DR, which is expressed typically on antigen-processing cells, has been also demonstrated on the glandular epithelial cells of the endometrium (16) . The expression of SC and DR on some cells and cell lines is modulated by cytokines such as interferon-gamma (IFN--/), interleukin-4 (IL-4), and tumor necrosis factor-alpha (TNF-a), all produced by T cells, suggesting roles for these molecules in mucosal immune responses (17) (18) (19) (20) .
The purpose of the present study was to examine the effects of different recombinant cytokines and estrogen on the expression of SC and DR on glandular epithelial cells from the human endometrium and two cell lines cloned from human endometrial adenocarcinomas.
MATERIALS AND METHODS

Endometrial Glandular Epithelial Cells
Samples of normal endometrium were obtained from six women undergoing surgery for nonneoplasic indications. Their age ranged from 35 to 45 years. The specimens were obtained primarily during the proliferative stage of the menstrual cycle. The tissues were maintained on ice until the endometrium was carefully dissected free of myometrium and cut into 5-to 8-mm sections for processing. The tissue was placed in 6-8 ml of 0.2% collagenase (Type II, Sigma Chemical Co, St. Louis, MO), 0.01% DNAase (Sigma) in 20 mM Hepes (Sigma)-buffered RPMI 1640 cell culture medium (CM) (Cellgro Mediatech, Washington, DC) (21) . Digestion was performed at 37°C with constant stirring for 30 min before the supernatant was replaced with fresh enzyme medium; three or four digestions were done, until the endometrial tissue was completely dispersed. The digested samples were mixed with an equal volume of CM containing 10% fetal calf serum (FCS) (Flow Laboratories, McLean, VA) in 15-ml conical centrifuge tubes and placed on ice. After 10-15 min the glands which settled to the bottom of the tubes were removed and resuspended in fresh CM-FCS to repeat the sedimentation process. The fractions containing primarily uterine glands suspended in 10% FCS in CM were plated in 25-cm 2 culture flasks (Coming, Corning, NY) for 1 hr, which allowed the stromal cells to attach to the plastic surface (22) . Epithelial glands did not firmly attach to the plastic surface during that interval. If stromal cells remained in the cell suspension, it was replated again for another hour. The CM containing the glands was removed from the flasks and distributed into a 24-well plate (Corning). The cells were allowed to reach confluency, usually occurring within 3-5 days, at which point treatment with cytokines was initiated. The CM was changed at 48 hr and at the start of the treatments. Estradiol-17B (E2) (Sigma) was added beginning the first day to some of the cultures at a 10 . 9 M final concentration.
Endometrial Adenocarcinoma Cell Lines
Two cell lines, HEC-1-A and RL95-2, were obtained from American Type Culture Collection, Rockville, MD. The lines were cultured in RPMI 1640 containing 10% FCS, 5 ~g bovine insulin, 100 U penicillin, and 50 Ixg streptomycin (Sigma) per ml.
Cytokines
The cytokines were added to the culture medium at the following concentrations per milliliter: 200-2000 U IFN-~/(Boehringer Mannheim, Germany), 2 ng IL-4, and 2 ng TNF-a (R&D Systems, Minneapolis, MN).
Immunofluorescence
The endometrial cells were removed from the wells of the plates by using trypsin-EDTA. After stripping, cells were resuspended in the CM at approximately 5 x 10 6 cells/ml and 50-~1 aliquots were pipetted into 1-ml microcentrifuge tubes and placed in a CO2 incubator for 2-2.5 hr to allow reexpression of surface markers (19). The cells were then centrifuged at 200g for 4 min, the supernatant removed, and 20 p~l of labeled or unlabeled antibodies to SC or DR added to each tube. The samples were incubated on ice for 30 min, then washed twice with cold PBS, and if the antibodies were directly labeled with fluorochromes, the cells were fixed with 1% paraformaldehyde for 20 min, washed with PBS, and mounted on a microslide for fluorescent microscopic observation. Coverslips were sealed using clear fingernail polish. If the first antibody was unlabeled, a second antibody (anti-Ig) labeled with fluorescein isothiocyanate (FITC) or tetramethyl rhodamine isothiocyanate (TRITC) was used with the cells after the wash. The antibodies consisted of the afffinity-purified IgG fraction of goat anti-human secretory component conjugated with FITC or TRITC (Dako, Carpinteria, CA), monodonal antibodies against HLA class II antigen (DR), and anticytokeratin peptide 16 (Becton Dickinson, Mountain View, CA). The second antibody, goat anti-mouse IgG labeled with FITC, was produced in the laboratory of JM. A minimum of 200 cells was counted for each labeled preparation. Slides were examined using a Leitz orthoplan microscope (Leitz Co., Wetzlar, Germany) with a superhigh-pressure mercury lamp.
Immunoglobulins
Human mIgA, pIgA, and IgM were isolated from serum samples of patients with IgA and IgM myelomas and IgG from normal human serum using classical Ig purification methods. (23, 24) Ten micrograms of the Ig's was added to suspensions of HEC and RL-95 cells (× 106) and kept on ice for 60 rain. The cells were washed twice with cold PBS, exposed to biotinylated-F(ab')2 antibodies against human IgA, IgG, or IgM (Tago, Burlingame, CA) for 45 min, and washed twice, and then avidin:FITC (Sigma) was added for a 30-rain incubation on ice. The cells were again washed, fixed, mounted, and observed as described above. 
Statistics
The data were analyzed by Student's t test and are p•esented as percentage mean + standard error of the mean (SE).
RESULTS
The cell cultures of the endometrial glands possessed the characteristics of epithelial cells in monolayer, as they appeared polyhedral in shape and arranged in swirls. Upon staining the epithelial cell cultures with the anticytokeratin antibody, more than 95% of the cells displayed cytoplasmic reactivity.
In the absence of E2, 6 + 3.2% of the epithelial cells displayed detectable SC on the surface (Fig.  1) . The addition of the cytokines IFN-y and IL-4 to the CM resulted in small and nonsignificant increases in the number of cells expressing SC. However, after adding E2 to the medium, the incidence of cells with detectable surface SC increased to 21 --+ 3.1%. With E2 present in the CM, the addition of the cytokines resulted in a further enhancement in the number of cells expressing SC: the addition of 2 ng of TNF-a increased the percentage to 39 ---6.9% and the combination of IFN-y and IL-4 to 37 __+ 3.5%. The combination of IFN-~ and TNF-a did not enhance SC expression above that induced by TNF-c~ alone (32 ___ 2.5 vs 39 _-_ 6.9%). DR antigen expression on the epithelial cell surface was independent of the presence of E 2 (Fig. 2) . Less than 6% of the cells were DR+ in the absence of any cytokines or Ez in the media. The addition of IFN-y to media without or with E2 induced 68 ---6. 25% of HEC and 80% of RL95 cells showed intense cytoskeleton staining.
Binding studies (n = 3) indicated that the majority of the HEC cells bound plgA (87 +--8.7%) and IgM (89 ± 7.9%) but little mlgA (14 -+ 5.3%) and less than 1% for IgG and a nonbinding IgM (Fig. 4) . The percentages of RL-95 cells binding the different Ig's were as follows: pIgA, 38 -3.3%; IgM, 41 ---7.8%; mlgA, 11 _ 3.6%; IgG and nonbinding IgM, 0%.
DISCUSSION
The results of our study confirm the report of Tabibzadeh et aL (16) that epithelial cells from the human endometrium respond to the T-cell cytokine IFN-~/by the induction of Class II HLA-DR expression on the cell membranes. IFN--¢ has been shown to also induce DR antigen on the surface of different cell types (18) . We report here that IL-4 also increased the level of DR expression on the endometrial cells.
However, expression of SC on the endometrial ceils was also influenced by the gonadal hormone estrogen. The effect of progesterone alone or with estrogen was not evaluated in the cell culture system. Immunocytochemical evaluation of SC expression by the human endometrium suggested, however, that secretion occurred throughout the menstrual cycle with maximum expression in the late secretory phase (11) . In vivo studies demonstrated the essential role of estrogen in inducing SC production by the endometrium in ovariectomized rats (25) . Contrary to the reported IFN-,/enhanced uterine SC secretion in ovariectomized rats, we did not observe such an increase in human cells cultured in vitro. The percentage of cells expressing membrane SC was shown by Sollid and co-workers (20) to be highly" associated with cellular production and secretion of SC using HT-29 human colonic adenocarcinoma ceils as a model system.
TNF-o~ exhibited a differential effect on expression of the two markers on endometrial cells: it significantly enhanced SC expression but showed little effect on DR expression. This was similar to results reported for colonic cell line HT-29 in which SC expression was increased by IFN-~/and TNF-a but DR was increased only by IFN-'y (18) . If the two cytokines were given together a synergistic effect on DR expression was then noted. In addition, IFN-,/ and IL-4 have demonstrated a synergistic effect on SC secretion by HT-29 cells (19). Inflammation of the gastric epithelial lining also caused an upregulation of SC expression, suggesting a role for the inflammatory cytokines, i.e., IFN-y and TNF-c~ (26) . These two cytokines are products of T lymphocytes and macrophages, respectively, which are found in elevated numbers in inflammed intestinal epithelia.
The two endometrial adenocarcinoma cell lines, unlike the endometrial epithelial cells and the HT-29 cell line, were not noticeably modulated as to the degree of SC and DR expression by IFN-% That the SC molecule on the epithelial cells and the cell lines was functional was in part demonstrated by its binding to pIgA and pIgM compared with the weak to nonexistent binding of mIgA, IgG, and a IgM known previously not to bind to SC. The incidence of labeled cells increased significantly with the indirect detection of SC after the addition of plgA and IgM in comparison to direct detection of SC with antibody. This observation was noted previously in a study on HT-29 cells (19). The binding affinity of pIgA for SC was estimated to be approximately two orders of magnitude greater than that of antibody for SC.
The endometrium is a mucosal tissue that is involved in the transport of pIgA and IgM. As in other mucosal tissues and organs, cytokines and hormones can enhance the efferent limb of the secretory immune system through the up regulation of SC production and expression. Epithelial cells from various mucosal tissues may respond differentially to cytokines if regulated by hormones, e.g., mammary glands and reproductive tissues are under primary control of the endocrine system reflecting their physiological functions of lactation and reproduction, whereas intestinal epithelia are directly affected by cytokines without the requirement for preconditioning by hormones (1) . In the absence of Ig-secreting plasma cells in the endometrium, serum-derived pIgA and IgM may be more important sources of S-IgA and S-IgM than local production. Transport of plgA from the serum across the respiratory epithelium has been demonstrated in mice (27, 28) . We observed similar results of the transfer of antibody activity of pIgA from serum into the female reproductive tract of mice (Renegar, Menge, and Mestecky, unpublished work).
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